Kaiser Peter Insider Trades & Stock Holdings

Chief Development Officer · Ocular Therapeutix, Inc. · Latest filing Oct 2, 2026

Kaiser Peter, Chief Development Officer at Ocular Therapeutix, Inc. has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($70.43K), net -$70.43K. Latest filing: disposed of 9.99K shares of $OCUL on Oct 2, 2026 at $7.05.

Trades on file

1

Open-market bought

$0

Open-market sold

$70.43K

Net open-market

-$70.43K

Latest filing

Oct 2, 2026

All insider trades by Kaiser Peter

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$OCUL	Sell (Open-market sale) 10b5-1	9.99K	$7.05	$70.43K			+8.3%			Chief Development Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kaiser Peter traded

• $OCUL

Frequently asked questions

Has Kaiser Peter been buying or selling stock?

Kaiser Peter has 0 open-market purchases and 1 open-market sale on file, net -$70.43K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kaiser Peter's latest insider trade?

disposed of 9.99K shares of $OCUL on Oct 2, 2026 at $7.05.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.